#United States #Morristown #PLT Health #Dynagenix #Joint Comfort

PLT Health Solutions' Dynagenix® Formula: Transforming Joint Comfort and Mobility

In a significant advancement for joint health, PLT Health Solutions, Inc., in partnership with Laila Nutraceuticals, has disclosed the successful results of a second clinical study on its innovative Dynagenix® Muscle+Joint Formula. This formulation, known for its low-dose Boswellia serrata extract, was designed to be mixed easily into beverages, making it highly versatile in various delivery systems.

The clinical study showcased impressive results, with participants experiencing marked improvements in joint comfort and overall mobility within just five days of using the formula. The study involved 72 adults aged 40 to 70 who participated in a randomized, double-blind, placebo-controlled trial over 30 days. Participants received either 40 mg/day of Dynagenix or a placebo, with results indicating significant benefits from the active ingredient.

Specifically, outcomes measured using the WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) scale revealed:

• - A 47% improvement in joint comfort
• - A 47% reduction in joint stiffness
• - A 45% enhancement in joint function
• - A 46% overall improvement in joint health

Additionally, functional performance assessments showed that subjects experienced a 25% increase in Chair Stand Test performance at two weeks, navigated stairs 25% faster (4 seconds quicker), walked 15.4% faster, and reported a 14% increase in flexibility by the end of the trial.

CEO Seth Flowerman highlighted the significance of these findings, noting that the research supports Dynagenix as a groundbreaking ingredient with rapid, effective results for both athletes and everyday individuals seeking relief from joint discomfort. "Whether you are recovering from physical activity or simply looking to enhance your daily mobility, Dynagenix brings measurable benefits to your routine," he stated.

This is not the first time Dynagenix has showcased its potential. A previous study conducted in 2019 indicated its effectiveness in reducing muscle soreness and promoting recovery. Participants who took 60 mg/day reported a 47% decrease in muscle soreness and a 31% reduction in joint discomfort while exercising. Impressively, 96% of subjects regained full strength by the third day of use, indicating that Dynagenix serves as a holistic solution for musculoskeletal health.

Warmer designs for the consumer market are in sight as the formulation's neutral taste and water-solubility allow it to be implemented across a wide array of consumer-friendly products. This adaptability paves the way for product developers to craft innovative offerings, such as ready-to-mix powders, functional gummies, shots, and stick-packs. These formats not only enhance the appeal of the product but also allow for easier incorporation into daily dietary routines.

Jennifer Murphy, Director of Innovation and Clinical Development at PLT, expressed her enthusiasm about the study's results, stating that they empower brands to foster superior joint health support in increasingly diverse and user-friendly formats. "With our low 40 mg effective dose, we aim to facilitate healthier, happier lives through easy-to-consume and enjoyable products," she said.

As PLT Health Solutions continues to explore avenues for joint health support and recovery, their commitment to quality and innovation reflects a broader trend in the nutraceutical industry. As the market evolves, products like Dynagenix will likely lead the charge for healthier lifestyles among consumers, particularly those managing aging and physical activity stresses.

For further information regarding the Dynagenix Muscle+Joint Formula and the latest clinical study results, interested parties can visit www.plthealth.com/dynagenix.